MedAdvisor

MedAdvisor Revenue per Share

Delisted

The Revenue per Share of MedAdvisor (MDR.AX) as of Oct 27, 2026 is 0.11 AUD. In the previous year, Revenue per Share was 0.18 AUD — a change of -37.96% (lower).

Revenue per Share

0.11AUD

YoY

-37.96%

Last updated:

Revenue per Share of MedAdvisor is 2025 0.11 AUD. Revenue per Share of MedAdvisor was 2024 0.18 AUD. It decreases by -37.96% lower compared to the previous year.

The MedAdvisor Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2021
0.13 AUD
Jan 1, 2022
0.18 AUD
Jan 1, 2023
0.18 AUD
Jan 1, 2024
0.18 AUD
Jan 1, 2025
0.11 AUD
Jan 1, 2026 (e)
0.20 AUD
Jan 1, 2027 (e)
0.20 AUD
Jan 1, 2028 (e)
0.21 AUD
The MedAdvisor Revenue per Share history
YEARRevenue per ShareYoY
est0.21AUD+3.69%
est0.20AUD+1.47%
est0.20AUD+75.68%
0.11AUD-37.96%
0.18AUD-0.13%
0.18AUD+0.33%
0.18AUD+40.79%
0.13AUD+166.62%
0.05AUD+0.89%
0.05AUD-83.78%
0.29AUD+642.91%
0.04AUD+80.75%
0.02AUD+86.37%
0.01AUD+2,751.43%
0.00AUD-75.13%
0.00AUD-65.17%
0.00AUD+73.89%
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

Revenue per Share of MedAdvisor is 0.11 AUD in 2025.

Revenue per Share of MedAdvisor changed from 0.18 AUD to 0.11 AUD, representing a -37.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MedAdvisor

All Key Metrics — MedAdvisor